Demant AS
DEMANT: XCSE (DNK)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|Lz | LOCK|?>>q | LOCK|y!R%!@W |
Demant Earnings: Oticon Zeal Drives Market Share Gains, High End of Guidance Now Likely
Demant reported first-quarter results with 6% organic and 11% reported sales growth, the latter boosted by the Kind acquisition. Management held its 2026 outlook intact, targeting 3%-6% organic growth and adjusted EBIT of DKK 4.10 billion–DKK 4.50 billion.
